生物資訊服務市場規模、佔有率和成長分析（按類型、應用、產業、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，生物資訊服務市場規模將達到 38.9 億美元，到 2025 年將成長至 45.1 億美元，到 2033 年將成長至 147 億美元，在預測期（2026-2033 年）內，複合年成長率為 15.9%。

受個人化醫療需求成長以及基因組學和蛋白​​質組學研究進展的推動，生物資訊服務市場正經歷顯著擴張。次世代定序技術產生的基因組數據呈現爆炸性成長，因此需要高效率的管理和解讀，進而推動了對生物資訊服務的需求。人工智慧和機器學習的融合增強了市場動態，促進了預測建模和藥物發現的進步。此外，雲端運算在資料儲存和分析領域的應用，以及對資料標準化和互通性的重視，也推動了市場成長。新興市場受惠於政府的支持性政策和對生物資訊學基礎設施的投資。整體而言，資訊和通訊技術的進步有望刺激研發活動，進一步推動該領域的市場發展。

生物資訊服務市場促進因素

個人化醫療（根據個人的基因譜和獨特特徵量身定做醫療保健解決方案）日益受到關注，這正顯著影響著生物資訊服務市場。這些服務對於分析和解讀基因組數據至關重要，能夠識別生物標記、評估疾病風險並最佳化治療策略。隨著個人化醫療需求的不斷成長，生物資訊服務在研究和臨床領域的應用也日益廣泛，凸顯了這些服務在改善醫療效果和提高整體醫療服務效率方面發揮的關鍵作用。

生物資訊服務市場的限制因素

由於生物資訊服務市場依賴大量的基因組和蛋白質組數據，因此面臨許多挑戰。生物數據的複雜性和變異性阻礙了標準化、無縫整合和嚴格品管的實現。不完整或不一致的數據會導致結果不準確，並妨礙對生物過程的準確解讀。反過來，這會對生物資訊服務的效率和可靠性產生負面影響，最終限制其在生命科學研究和應用領域中發揮潛在作用和發揮效力。應對這些挑戰對於該領域的持續發展和成功至關重要。

生物資訊服務市場的發展趨勢

生物資訊服務市場正經歷著向雲端解決方案的重大轉型，其特點是對可擴展性、成本效益和增強協作能力的需求日益成長。研究人員和機構擴大採用雲端平台進行資料儲存、分析和共用，有效緩解了傳統本地部署基礎設施帶來的挑戰。這一趨勢透過提供靈活的運算資源存取和促進跨地域協作，推動了創新並加速了研究成果的產出。隨著生物數據量的持續飆升，雲端運算已成為生物資訊領域不可或缺的工具，有望推動該領域的成長並革新調查方法。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

全球生物資訊服務市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 定序服務
• 數據分析
• 藥物發現服務
• 差異基因表現分析
• 資料庫和管理服務
• 其他生物資訊服務

全球生物資訊服務市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 基因組學
  • 功能基因體學
  • 結構基因體學
  • 比較基因組學
• 化學資訊學與藥物設計
• 蛋白質體學
  • 蛋白質鑑定
  • 蛋白質結構預測
• 轉錄組學
• 代謝體學
• 其他

全球生物資訊服務市場規模（按產業分類）及複合年成長率（2026-2033 年）

• 醫療保健
  • 臨床診斷
  • 藥物發現與開發
• 動物
  • 獸醫診斷
  • 畜牧養殖
• 農業
  • 作物改良
  • 有害生物防治
• 學術的
  • 研究計劃
  • 教育計劃

全球生物資訊服務市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 學術機構與研究中心
• 醫院和診所
• 製藥和生物技術公司
• CRO
• 其他

全球生物資訊服務市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Illumina, Inc.（USA）
• QIAGEN（Germany）
• Thermo Fisher Scientific Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• BGI Group（China）
• IBM Life Sciences（USA）
• Waters Corporation（USA）
• Partek Incorporated（USA）
• Biomatters Ltd.（New Zealand）
• Macrogen, Inc.（South Korea）
• DNASTAR, Inc.（USA）
• GenoSpace（USA）
• Nonlinear Dynamics Ltd.（UK）
• Molecular Connections Pvt. Ltd.（India）
• Eagle Genomics Ltd.（UK）
• SOPHiA GENETICS（Switzerland）
• Seven Bridges Genomics（USA）
• InSilixa Inc.（USA）

結論與建議

Bioinformatics Services Market size was valued at USD 3.89 Billion in 2024 and is poised to grow from USD 4.51 Billion in 2025 to USD 14.7 Billion by 2033, growing at a CAGR of 15.9% during the forecast period (2026-2033).

The bioinformatics services market is experiencing significant expansion, driven by a rising demand for personalized medicine and advancements in genomics and proteomics research. The surge in genomic data from next-generation sequencing technologies necessitates efficient management and interpretation, increasing the need for bioinformatics services. The incorporation of AI and machine learning is enhancing market dynamics, facilitating advancements in predictive modeling and drug discovery. Additionally, the adoption of cloud computing for data storage and analytics is fostering growth, alongside the emphasis on data standardization and interoperability. Emerging markets are benefiting from supportive government policies and investments in bioinformatics infrastructure. Overall, improvements in information and communication technology are anticipated to stimulate R&D efforts, further propelling market development in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioinformatics Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioinformatics Services Market Segments Analysis

Global Bioinformatics Services Market is segmented by type, application, sector, end user and region. Based on type, the market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services and other bioinformatics services. Based on application, the market is segmented into genomics, cheminformatics & drug design, proteomics, transcriptomics, metabolomics and others. Based on sector, the market is segmented into medical, animal, agricultural and academics. Based on end user, the market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, Cros and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioinformatics Services Market

The increasing focus on personalized medicine, which seeks to deliver customized healthcare solutions tailored to an individual's genetic profile and distinct characteristics, is significantly influencing the Bioinformatics Services market. These services are essential for the analysis and interpretation of genomic data, enabling the identification of biomarkers, assessing disease risk, and refining treatment strategies. As the need for personalized healthcare continues to escalate, the adoption of bioinformatics services in research and clinical environments is also on the rise, highlighting their pivotal role in advancing medical outcomes and enhancing the overall effectiveness of healthcare delivery.

Restraints in the Bioinformatics Services Market

The Bioinformatics Services market faces significant challenges due to its dependence on extensive genomic and proteomic data. The intricate nature and variability of biological data create obstacles in achieving standardization, seamless integration, and stringent quality control. When data is incomplete or inconsistent, it can result in inaccurate findings and hinder the precise interpretation of biological processes. This, in turn, adversely affects the efficiency and reliability of bioinformatics services, ultimately limiting their potential impact and effectiveness in advancing research and applications in the life sciences. Addressing these issues is crucial for the continued growth and success of the sector.

Market Trends of the Bioinformatics Services Market

The bioinformatics services market is witnessing a significant shift towards cloud-based solutions, characterized by an increasing demand for scalability, cost-efficiency, and enhanced collaborative capabilities. Researchers and organizations are increasingly adopting cloud platforms for data storage, analysis, and sharing, which effectively mitigate the challenges posed by traditional on-premises infrastructures. This trend is fostering innovation and accelerating research outcomes, as it allows for more flexible access to computational resources and facilitates collaboration across geographic boundaries. As the volume of biological data continues to surge, cloud computing is poised to become an indispensable tool in the bioinformatics landscape, driving growth and modernizing research methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Bioinformatics Services Market Size by Type & CAGR (2026-2033)

• Market Overview
• Sequencing Services
• Data Analysis
• Drug Discovery Services
• Differential Gene Expression Analysis
• Database And Management Services
• Other Bioinformatics Services

Global Bioinformatics Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Genomics
  • Functional Genomics
  • Structural Genomics
  • Comparative Genomics
• Cheminformatics & Drug Design
• Proteomics
  • Protein Identification
  • Protein Structure Prediction
• Transcriptomics
• Metabolomics
• Others

Global Bioinformatics Services Market Size by Sector & CAGR (2026-2033)

• Market Overview
• Medical
  • Clinical Diagnostics
  • Drug Discovery & Development
• Animal
  • Veterinary Diagnostics
  • Animal Breeding
• Agricultural
  • Crop Improvement
  • Pest Control
• Academics
  • Research Projects
  • Educational Programs

Global Bioinformatics Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic Institutes & Research Centers
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Cros
• Other

Global Bioinformatics Services Market Size & CAGR (2026-2033)

• North America (Type, Application, Sector, End User)
  • USA
  • Canada
• Europe (Type, Application, Sector, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Sector, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Sector, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Sector, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Life Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Partek Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomatters Ltd. (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNASTAR, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenoSpace (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nonlinear Dynamics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Connections Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eagle Genomics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOPHiA GENETICS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSilixa Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations